Scholarlink

<p>This review summarizes the current literature on the use of wearable devices for collecting physiological data in pediatric and young adult (0−25 years) oncology. Searches were conducted in MEDLINE, PubMed and Embase, focusing on pediatric and young adult patients with a cancer diagnosis, and utilizing a wearable device during and/or after treatment. Of the 77 articles that met the inclusion criteria, 61 studies primarily used wearable devices as a tool to monitor physiological changes in an interventional or observational setting. Only 16 studies integrated wearable devices as an active component of the intervention. The most reported wearable device brands were ActiGraph (19, 24.7%), FitBit (14, 18.2%), Ambulatory Monitoring Inc. (11, 14.3%) and Philips Respironics (10, 13%). This scoping review offers valuable insights into the current use of wearable devices in pediatric and young adult (0−25 years) oncology but also reveals notable gaps in the literature.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Scoping review of the utilization of wearable devices in pediatric and young adult oncology

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月31日

查看全文
  • Lane Collier,
  • Sarah L. Grimshaw,
  • Julian Stolper,
  • Elyse Passmore,
  • Gareth Ball,
  • David A. Elliott,
  • Rachel Conyers

摘要

This review summarizes the current literature on the use of wearable devices for collecting physiological data in pediatric and young adult (0−25 years) oncology. Searches were conducted in MEDLINE, PubMed and Embase, focusing on pediatric and young adult patients with a cancer diagnosis, and utilizing a wearable device during and/or after treatment. Of the 77 articles that met the inclusion criteria, 61 studies primarily used wearable devices as a tool to monitor physiological changes in an interventional or observational setting. Only 16 studies integrated wearable devices as an active component of the intervention. The most reported wearable device brands were ActiGraph (19, 24.7%), FitBit (14, 18.2%), Ambulatory Monitoring Inc. (11, 14.3%) and Philips Respironics (10, 13%). This scoping review offers valuable insights into the current use of wearable devices in pediatric and young adult (0−25 years) oncology but also reveals notable gaps in the literature.